Barbara Brigitta Bendlin
Works at
Sources: reporter.nih.gov
Grants and prizes
R01, ß-hydroxybutyrate inhibition of pathology in Alzheimer's disease, R01AG083883, 2023–2028, 7 Aug 2026
R01, CRCNS: Repurposing Transformers to Characterize Gut Microbiome & Aging Brain Axis, R01AG092220, 2024–2028, 5 Jun 2026
R61, Gut microbiome intervention in preclinical and clinical Alzheimer's disease, R61AG088913, 2025–2027, 24 Apr 2026
R21, Exploring the role of Imidazole Propionate on Alzheimer’s Disease and Related Dementias, R21AG089348, 2024–2027, 2 May 2025
R01, The Neighborhoods Study: Contextual Disadvantage and Alzheimer’s Disease and Related Dementias (ADRD), R01AG070883, 2021–2026, 12 Mar 2025
R01, Gut barrier function in Alzheimer’s disease, R01AG070973, 2021–2026, 14 Feb 2025
R01, White matter degeneration: biomarkers in preclinical Alzheimer's Disease, R01AG037639, 2012–2024, 18 May 2023
Sources: reporter.nih.gov